Vericel Corp (VCEL)
45.12
-0.99
(-2.15%)
USD |
NASDAQ |
Apr 25, 12:11
Vericel Price: 45.12 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 46.51 | 46.87 | 46.04 | 46.11 | 199486.0 |
Apr 23, 2024 | 45.59 | 47.14 | 45.42 | 46.42 | 362327.0 |
Apr 22, 2024 | 44.16 | 45.72 | 43.88 | 45.38 | 300916.0 |
Apr 19, 2024 | 43.67 | 44.50 | 42.38 | 43.74 | 522006.0 |
Apr 18, 2024 | 46.06 | 46.56 | 43.69 | 43.86 | 426930.0 |
Apr 17, 2024 | 47.94 | 47.94 | 45.98 | 46.26 | 319426.0 |
Apr 16, 2024 | 48.16 | 48.61 | 46.88 | 47.52 | 245185.0 |
Apr 15, 2024 | 48.41 | 49.24 | 47.90 | 48.70 | 352368.0 |
Apr 12, 2024 | 48.64 | 48.93 | 46.94 | 47.90 | 301434.0 |
Apr 11, 2024 | 49.49 | 49.79 | 48.46 | 48.72 | 222146.0 |
Apr 10, 2024 | 48.84 | 49.78 | 48.38 | 49.18 | 363913.0 |
Apr 09, 2024 | 50.29 | 50.41 | 48.93 | 50.34 | 310429.0 |
Apr 08, 2024 | 51.44 | 51.44 | 50.17 | 50.23 | 262750.0 |
Apr 05, 2024 | 50.08 | 51.71 | 49.61 | 51.07 | 321181.0 |
Apr 04, 2024 | 51.47 | 51.84 | 50.27 | 50.42 | 280385.0 |
Apr 03, 2024 | 50.96 | 52.19 | 50.27 | 51.33 | 455124.0 |
Apr 02, 2024 | 52.50 | 52.50 | 51.23 | 51.26 | 603336.0 |
Apr 01, 2024 | 52.60 | 53.05 | 51.57 | 52.90 | 480779.0 |
Mar 28, 2024 | 52.44 | 52.50 | 51.50 | 52.02 | 473847.0 |
Mar 27, 2024 | 50.25 | 52.43 | 50.25 | 52.33 | 576962.0 |
Mar 26, 2024 | 48.13 | 49.82 | 48.13 | 49.56 | 758196.0 |
Mar 25, 2024 | 47.06 | 48.34 | 46.99 | 47.94 | 767149.0 |
Mar 22, 2024 | 46.90 | 47.28 | 45.59 | 46.90 | 840501.0 |
Mar 21, 2024 | 46.00 | 46.93 | 45.82 | 46.69 | 743356.0 |
Mar 20, 2024 | 45.27 | 46.00 | 44.44 | 45.75 | 390347.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.25
Minimum
Mar 18 2020
67.81
Maximum
Jun 28 2021
30.90
Average
29.98
Median
Price Benchmarks
Arbutus Biopharma Corp | 2.705 |
Chimerix Inc | 0.8972 |
Karyopharm Therapeutics Inc | 1.05 |
Axsome Therapeutics Inc | 71.74 |
Y-mAbs Therapeutics Inc | 15.11 |
Price Related Metrics
PS Ratio | 10.87 |
Price to Book Value | 9.643 |
Price to Free Cash Flow | 275.36 |
Earnings Yield | -0.18% |
Market Cap | 2.179B |